表紙
市場調查報告書

語音生物標記的市場規模:類型,適應症,神經疾病,各終端用戶趨勢分析,市場競爭模式與展望(2021年∼2026年)

Global Vocal Biomarker Market By Type, By Indications, By Neurological disorders, By End-user ; Trend Analysis, Market Competition Scenario & Outlook, 2021-2026.

出版商 Blueweave Consulting & Research Private Limited 商品編碼 954908
出版日期 內容資訊 英文 169 Pages
商品交期: 最快1-2個工作天內
價格
語音生物標記的市場規模:類型,適應症,神經疾病,各終端用戶趨勢分析,市場競爭模式與展望(2021年∼2026年) Global Vocal Biomarker Market By Type, By Indications, By Neurological disorders, By End-user ; Trend Analysis, Market Competition Scenario & Outlook, 2021-2026.
出版日期: 2020年08月01日內容資訊: 英文 169 Pages
簡介

語音生物標誌物的市場規模在2019年達到17.3億美元。在2020年至2026年的預測期內,市場預計將以13.7%的複合年增長率增長,到2026年將達到42億美元。語音生物標誌是用於早期發現疾病的醫療設備。它的市場是由神經和心理疾病的流行以及疾病檢測的緊迫性所推動。此外,它的成本效益和技術進步也促進了市場的增長。在過去的幾年中,市場一直以穩定的速度增長。目前,製藥公司和醫療保健部門正在探索其在醫療領域的應用和潛力。安全機構和國防組織越來越多地使用語音生物標記對嫌疑犯進行測謊測試。

本報告提供全球語音生物標記的市場規模相關調查調查,提供市場機會和課題,成長及阻礙因素,類型·適應症·神經疾病·終端用戶·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 調查架構

第2章 調查手法

第3章 摘要整理

第4章 全球語音生物標記的洞察

  • 產業的價值鏈分析
  • DROC分析
    • 成長要素
    • 阻礙因素
    • 市場機會
    • 課題
  • 技術形勢
  • 法律規範
  • 企業的市場佔有率分析(2019)
  • 波特的五力分析
  • 策略性展望

第5章 市場概要

  • 各銷售額市場估計·預測(2016-2026)
    • 各銷售額
  • 市場佔有率與預測
    • 各類型
      • 頻率
      • 振幅
      • 錯誤率
      • 語音上升/下降時間
      • 發音時間
      • 聲音震顫
      • 節距
      • 其他
    • 適應症
      • 憂鬱症
      • 注意缺點
      • 破壞性行為障礙
      • 其他
    • 各神經疾病
      • 帕金森氏症
      • 阿茲海默症
      • 亨丁頓舞蹈症
      • 呼吸系統·心血管疾病
      • 創傷性腦損傷
    • 終端用戶
      • 醫院·診療所
      • 學術·研究
      • 其他
    • 各地區
      • 北美
      • 歐洲
      • 亞太地區
      • 南美
      • 中東·非洲

第6章 北美市場

  • 各銷售額市場估計·預測(2016-2026)
    • 各銷售額
  • 市場佔有率與預測
    • 各類型
    • 各適應症
    • 各神經病變
    • 各終端用戶
    • 各國
      • 美國
      • 加拿大

第7章 歐洲市場

  • 各銷售額市場估計·預測(2016-2026)
    • 各銷售額
  • 市場佔有率與預測
    • 各類型
    • 各適應症
    • 各神經病變
    • 各終端用戶
    • 各國
      • 德國
      • 英國
      • 法國
      • 義大利
      • 其他

第8章 亞太地區市場

  • 各銷售額市場估計·預測(2016-2026)
    • 各銷售額
  • 市場佔有率與預測
    • 各類型
    • 各適應症
    • 各神經病變
    • 各終端用戶
    • 各國
      • 中國
      • 印度
      • 日本
      • 韓國
      • 其他

第9章 南美市場

  • 各銷售額市場估計·預測(2016-2026)
    • 各銷售額
  • 市場佔有率與預測
    • 各類型
    • 各適應症
    • 各神經病變
    • 各終端用戶
    • 各國
      • 巴西
      • 墨西哥
      • 阿根廷
      • 其他

第10章 中東及非洲市場

  • 各銷售額市場估計·預測(2016-2026)
    • 各銷售額
  • 市場佔有率與預測
    • 各類型
    • 各適應症
    • 各神經病變
    • 各終端用戶
    • 各國
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 南非
      • 其他

第11章 企業簡介 (企業概要,財務矩陣,產品形勢,主要員工,主要競爭,聯絡原住所,及策略性展望)

  • Sonde Health
  • Beyond Verbal
  • IBM Corporation
  • Cogito Corporation
  • Boston Technology Corporation
  • Microtest Health

策略性建議

目錄
Product Code: BWC20123

Title:
Global Vocal Biomarker Market By Type (Frequency, Amplitude, Error Rate, Voice Rise/fall time, Phonation Time, Voice Tremor, Pitch and Others), By Indications (Depression, Attention Deficit and Disruptive Behavior Disorders and Others), By Neurological disorders (Parkinson's Disease, Alzheimer's Disease, Huntington's Disease, Respiratory and Cardiovascular Disorders, Traumatic Brain Injury), By End-user (Hospitals and Clinics, Academic and Research, Others); Trend Analysis, Market Competition Scenario & Outlook, 2021-2026..

"Global Vocal Biomarker Market expected to reach USD 4.2 Billion in 2026 at a significant CAGR of 13.7 %"

According to Blueweave Consulting, the Global Vocal Biomarker Market is anticipated to reach USD 4.2 Billion in 2026 from USD 1.73 Billion in 2019, at CAGR of 13.7% during the projected period 2020-26. Global Vocal Biomarker is a medical device used for the early detection of diseases. Its market is driven by the prevalence of neurological and psychological diseases and the urgency of disease detection. Besides, its cost-efficiency and technological advancements induce market growth. The market has been growing at a steady rate during the past few years. At present, the Pharma companies and the healthcare sector are exploring its applications and potential in the medical field. The security agencies and defence organizations are increasingly using Vocal Biomarker for the lie-detecting test of the suspects. The market holds tremendous growth potential due to technological advancements, including AI, and is expected to register growth during the forthcoming period.

Vocal Biomarker is a device that detects ailments based on the voice pattern of the patient. It is a minimally invasive technique deployed for the diagnosis of diseases in the initial stage. It serves as a substitute for MRI, X-Ray, and CT Scan in medical urgencies. The advance uses of this technique facilitate the diagnosis and treatment of diseases besides lie-detection tests. The vocal Biomarker serves as a remote sensor for patients with fatal diseases and helps recognize a medical emergency. In COVID times, its application is more relevant and is being deployed in different countries for different medical purposes.

However, the accuracy of vocal bio-markers may vary depending on the complexity of spoken words and the surroundings of the speech recording. Besides, the inability to extract the desired vocal features, significant errors in the vocal features, and inaccuracies of boundaries of words also restrict the use of vocal Biomarker, hampering its market growth.

The vocal biomarker market is segregated into four categories viz., four categories viz., Type, Indications, Neurological Disorders, and End-user. In the first category, different speech features are analyzed, and voice tremor is the most explored segment in this category. The Indication category is subdivided into Depression, Attention Deficit and Disruptive Behavior Disorders, and Others. Among subdivisions based on diseases, Parkinson's disease division dominates the vocal biomarker market. While in the end-user category, the healthcare sector is the prominent user of the vocal biomarkers and holds a significant share.

"The Dominating segments in the Global Vocal Biomarkers Market are Voice Tremor recognition and Parkinson's disease."

In the first category based on type, the voice tremor segment is expected to register significant growth due to rising neurological disorders and growing application of vocal Biomarker in it. As per a study of Parkinson's Foundation, more than 10 million across the globe suffer from Parkinson's disease. The prevalence, risk, early detection requirement, and increasing cases of this disease lead to the more demand for vocal Biomarker, assuring strong growth potential for the market.

"The key drivers of Global Vocal Biometric Markets are Growing applications in expanding the healthcare sector and the prevalence of Parkinson's Disease."

The vocal biomarkers find their application in remote health monitoring of the heart-patient, in the testing voice of the patient with coronary artery disease and recognizing depression and stress among callers besides early detection of diseases in healthcare. The healthcare facilities are widening its use in diagnosis and treatment, which drives the Global Vocal Biomarker Market. The widespread Parkinson's disease also drives the market for risk detection, monitoring, and prevention.

"North America Dominates the Market Due to Advanced Healthcare Facilities."

North America has a robust healthcare infrastructure consisting of well-established healthcare facilities and advanced technologies for diagnosis and treatment, so it is expected to dominate the Global Vocal Biomarker Market during the projection period. Besides, easy medical reimbursement policies and increasing healthcare expenditure in the region contribute to the market's growth. Europe is the second most promising market driven by increasing healthcare outlay and rising income & awareness. Asia Pacific region is anticipated to register growth driven by the markets in China, India, Japan, and South Korea.

"The leading players" in this market are Sonde Health(US), Beyond Verbal (Israel), IBM Corporation (US), Cogito Corporation (US), Boston Technology Corporation, Microtest Health, and others.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Research Methodology

  • 2.1. Qualitative Research
    • 2.1.1. Primary & Secondary Sources
  • 2.2. Quantitative Research
    • 2.2.1. Primary & Secondary Sources
  • 2.3. Market Breakdown & Data Triangulation
    • 2.3.1. Secondary Research
    • 2.3.2. Primary Research
  • 2.4. Regional Classification of Primary Research Respondents
  • 2.5. Assumptions & Limitations

3. Executive Summary

4. Global Vocal Biomarker Insights

  • Industry Value Chain Analysis
  • DROC Analysis
    • Growth Drivers
    • Restraints
    • Opportunities
    • Challenges
  • Technological Landscape
  • Regulatory Framework
  • Company Market Share Analysis,2019
  • Porter's Five forces analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Threat of Substitutes
    • Intensity of Rivalry
  • Strategic Outlook

5. Global Vocal Biomarker Market Overview

  • Market Estimates & Forecast By Value, 2016-2026
    • By Value (USD)
  • Market Share & Forecast
    • 5.2.1. By Type
      • 5.2.1.1. Frequency
      • 5.2.1.2 Amplitude
      • 5.2.1.3 Error Rate
      • 5.2.1.4 Voice Rise/fall time
      • 5.2.1.5 Phonation Time
      • 5.2.1.6 Voice Tremor
      • 5.2.1.7 Pitch
      • 5.2.1.8 Others
    • 5.2.2. By Indications
      • 5.2.2.1. Depression
      • 5.2.2.2 Attention Deficit
      • 5.2.2.3 Disruptive Behavior Disorders
      • 5.2.2.4 Others
    • 5.2.3. By Neurological Disorder
      • 5.2.3.1 Parkinsons Disease
      • 5.2.3.2 Alzheimer's Disease
      • 5.2.3.3 Huntington's Disease
      • 5.2.3.4 Respiratory and Cardiovascular Disorders
      • 5.2.3.5 Traumatic Brain Injury
    • 5.2.4. By End-User
      • 5.2.4.1 Hospital and Clinics
      • 5.2.4.2 Academic and Research
      • 5.2.4.3 Others
    • 5.2.5 By Region
      • 5.2.5.1. North America
      • 5.2.5.2. Europe
      • 5.2.5.3. Asia Pacific
      • 5.2.5.4. South America
      • 5.2.5.5. Middle East & Africa

6. North America Vocal Biomarker Market

  • Market Estimates & Forecast By Value, 2016-2026
    • By Value (USD)
  • Market Share & Forecast
    • By Type
    • By Indications
    • By Neurological Disorder
    • By End-User
    • By Country
      • U.S
      • Canada

7. Europe Vocal Biomarker Market

  • Market Estimates & Forecast By Value, 2016-2026
    • By Value (USD)
  • Market Share & Forecast
    • By Type
    • By Indications
    • By Neurological Disorder
    • By End-User
    • By Country
      • Germany
      • U.K
      • France
      • Italy
      • Rest of Europe

8. Asia Pacific Vocal Biomarker Market

  • Market Estimates & Forecast By Value, 2016-2026
    • By Value (USD)
  • Market Share & Forecast
    • By Type
    • By Indications
    • By Neurological Disorder
    • By End-User
    • By Country
      • China
      • India
      • Japan
      • South Korea
      • Rest of APAC

9. South America Vocal Biomarker Market

  • Market Estimates & Forecast By Value, 2016-2026
    • By Value (USD)
  • Market Share & Forecast
    • By Type
    • By Indications
    • By Neurological Disorder
    • By End-User
    • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America

10. Middle East & Africa Vocal Biomarker Market

  • Market Estimates & Forecast By Value, 2016-2026
    • By Value (USD)
  • Market Share & Forecast
    • By Type
    • By Indications
    • By Neurological Disorder
    • By End-User
    • By Country
      • Saudi Arabia
      • UAE
      • South Africa
      • Rest of MEA

11. Company Profile (Company Overview, Financial Matrix, Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook)*

  • 11.1 Sonde Health( US),
  • 11.2 Beyond Verbal (Israel),
  • 11.3 IBM Corporation (US),
  • 11.4 Cogito Corporation (US),
  • 11.5 Boston Technology Corporation,
  • 11.6 Microtest Health)

Strategic Recommendation

*Financial Details Not Be Captured in Case of Unlisted Companies

**The segmentation and the companies are subjected to modifications based on the in-depth secondary for the final deliverable